Lumason® Infusion vs. Bolus Administrations

NCT06400004 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Diseases

Interventions

DRUG: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
DRUG: Lumason

Sponsor

Bracco Diagnostics, Inc